Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Paraflex Tablets

Paraflex Tablets

NAFDAC Reg. No. A4-8018 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 5 November 2026 · synced automatically from official sources.
Producto
Paraflex Tablets
Número NAFDAC
A4-8018
Principio activo
Chlorzoxazone; Paracetamol
Dosis
250 mg; 500 mg
Forma
Tablet
Fabricante
No Constan
Solicitante (titular)
Franphino Pharmaceuticals Nigeria Limited
Approved
21 Dec 2020
Estado
Inactive Ver en NAFDAC ↗
Registro válido hasta
20 Dec 2025
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Chlorzoxazone: uses, dosage and brands worldwide

Lo que encontramos

  • Paraflex Tablets is on the NAFDAC register with an active registration (A4-8018). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Paraflex Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

INDICATIONS Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.

Cómo tomarlo y con qué frecuencia
  • Usual Adult Dosage One tablet three or four times daily
  • If adequate response is not obtained with this dose, it may be increased to one and one-half tablets (750 mg) three or four times daily
  • As improvement occurs dosage can usually be reduced
Talk to a doctor first if

Chlorzoxazone is contraindicated in patients with known intolerance to the drug.

Warnings

Serious (including fatal) hepatocellular toxicity has been reported rarely in patients receiving chlorzoxazone. The mechanism is unknown but appears to be idiosyncratic and unpredictable. Factors predisposing patients to this rare event are not known. Patients should be instructed to report early signs and/or symptoms of hepatotoxicity such as fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, or jaundice. Chlorzoxazone should be discontinued immediately and a physician consulted if any of these signs or symptoms develop. …

Posibles efectos secundarios

Chlorzoxazone containing products are usually well tolerated. It is possible in rare instances that chlorzoxazone may have been associated with gastrointestinal bleeding. Drowsiness, dizziness, lightheadedness, malaise, or over-stimulation may be noted by an occasional patient. Rarely, allergic type skin rashes, petechiae, or ecchymoses may develop during treatment. Angioneurotic edema or anaphylactic reactions are extremely rare. There is no evidence that the drug will cause renal damage. Rarely, a patient may note discoloration of the urine resulting from a phenolic metabolite of chlorzoxazone. This finding is of no known clinical significance. …

If you take too much

Symptoms Initially, gastrointestinal disturbances such as nausea, vomiting, or diarrhea together with drowsiness, dizziness, lightheadedness or headache may occur. Early in the course there may be malaise or sluggishness followed by marked loss of muscle tone, making voluntary movement impossible. The deep tendon reflexes may be decreased or absent. The sensorium remains intact, and there is no peripheral loss of sensation. Respiratory depression may occur with rapid, irregular respiration and intercostal and substernal retraction. …

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-03-01.

Label for chlorzoxazone and paracetamol, the active ingredient registered with NAFDAC.

Check your pack of Paraflex Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Paraflex Tablets

What is in Paraflex Tablets?

Paraflex Tablets contains Chlorzoxazone; Paracetamol (250 mg; 500 mg), as tablet, according to its NAFDAC registration record.

Is Paraflex Tablets registered with NAFDAC?

Yes. Paraflex Tablets is listed on the NAFDAC register under registration number A4-8018, and its registration is active as of 5 November 2026.

Has Paraflex Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Paraflex Tablets in our automatically synced alert list.

How can I check that my pack of Paraflex Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-8018, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Paraflex Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Usual Adult Dosage One tablet three or four times daily. If adequate response is not obtained with this dose, it may be increased to one and one-half tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.…

What is Paraflex Tablets used for?

INDICATIONS Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man. (Summarised from the official U.S. FDA label for chlorzoxazone and paracetamol. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Paraflex Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.